SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : MDA - Market Direction Analysis
SPY 660.19-0.8%4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: marginmike who wrote (48899)5/2/2000 9:54:00 AM
From: Casaubon  Read Replies (1) of 99985
 
The only way interest rates effect biotechs is the guaranteed rate of return one gets buying bonds instead of stock. No matter how high the interest rate goes, if you need a drug to alleviate a medical condition, you will buy it. Interest rates don't effect disease statistics. One could argue that higher interest rates will cause a recession which would lead to unemployment, and that would result in more people who do not have health insurance, and therefore could not afford to buy the necessary drugs. However, I find that scenario to be ridiculous. The only way promising biotech companies will fall apart is if they have failures in the clinic or somebody beats them to the punch.

All just my opinion, of course.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext